Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart Failure: The EVEREST Clinical Status Trials
Article submitted by HMHB at 17:04, Thu 29 Mar 2007
PMID: 17384438
Objective To evaluate short-term effects of tolvaptan when added to standard therapy in patients hospitalized with heart failure.
Conclusion In patients hospitalized with heart failure, oral tolvaptan in addition to standard therapy including diuretics improved many, though not all, heart failure signs and symptoms, without serious adverse events.
Conclusion In patients hospitalized with heart failure, oral tolvaptan in addition to standard therapy including diuretics improved many, though not all, heart failure signs and symptoms, without serious adverse events.
Conflict of Interests - none